M P Muller

Summary

Affiliation: Mount Sinai Hospital
Country: Canada

Publications

  1. ncbi Clinical and epidemiologic features of group a streptococcal pneumonia in Ontario, Canada
    Matthew P Muller
    Department of Microbiology, Mount Sinai Hospital, 600 University Ave, Toronto, Ontario, Canada M5G 1X5
    Arch Intern Med 163:467-72. 2003
  2. ncbi Febrile respiratory illness in the intensive care unit setting: an infection control perspective
    Matthew P Muller
    Department of Internal Medicine, Infectious Diseases Division, University of Toronto, Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5
    Curr Opin Crit Care 12:37-42. 2006
  3. ncbi Early diagnosis of SARS: lessons from the Toronto SARS outbreak
    M P Muller
    Department of Microbiology, Mount Sinai Hospital, 600 University Avenue, M5G 1X5 Toronto, Canada
    Eur J Clin Microbiol Infect Dis 25:230-7. 2006
  4. ncbi Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome
    Matthew P Muller
    Department of Microbiology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
    Pharmacotherapy 27:494-503. 2007
  5. ncbi Severe acute respiratory syndrome
    Michael D Christian
    Toronto General Hospital, University Health Network, Toronto, Ontario, Canada
    Clin Infect Dis 38:1420-7. 2004
  6. ncbi Rapid control of a methicillin resistant Staphylococcus aureus (MRSA) outbreak in a medical surgical intensive care unit (ICU)
    Anjum Khan
    St Michael s Hospital, Toronto, Ontario, Canada
    Can J Infect Control 24:12-6. 2009
  7. ncbi Clinical trials and novel pathogens: lessons learned from SARS
    Matthew P Muller
    Mount Sinai Hospital, Toronto, Ontario, Canada
    Emerg Infect Dis 10:389-94. 2004
  8. ncbi Severe acute respiratory syndrome (SARS) coronavirus
    Matthew P Muller
    Department of Microbiology, Mount Sinai Hospital, Toronto, Ontario, Canada
    Semin Respir Crit Care Med 28:201-12. 2007
  9. ncbi Impact of a mandatory infection control education program on nosocomial acquisition of methicillin-resistant Staphylococcus aureus
    Todd C Lee
    University of Toronto, Canada
    Infect Control Hosp Epidemiol 30:249-56. 2009
  10. ncbi One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome
    Catherine M Tansey
    Department of Medicine, University Health Network, and Mount Sinai Hospital, Toronto, Ontario, Canada
    Arch Intern Med 167:1312-20. 2007

Collaborators

Detail Information

Publications17

  1. ncbi Clinical and epidemiologic features of group a streptococcal pneumonia in Ontario, Canada
    Matthew P Muller
    Department of Microbiology, Mount Sinai Hospital, 600 University Ave, Toronto, Ontario, Canada M5G 1X5
    Arch Intern Med 163:467-72. 2003
    ..Progression is rapid despite appropriate therapy. The incidence is similar to, and the case fatality rate higher than, that of necrotizing fasciitis...
  2. ncbi Febrile respiratory illness in the intensive care unit setting: an infection control perspective
    Matthew P Muller
    Department of Internal Medicine, Infectious Diseases Division, University of Toronto, Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5
    Curr Opin Crit Care 12:37-42. 2006
    ....
  3. ncbi Early diagnosis of SARS: lessons from the Toronto SARS outbreak
    M P Muller
    Department of Microbiology, Mount Sinai Hospital, 600 University Avenue, M5G 1X5 Toronto, Canada
    Eur J Clin Microbiol Infect Dis 25:230-7. 2006
    ..Other clinical, laboratory and radiographic findings further raise or lower the likelihood of SARS and provide a rational basis for estimating the likelihood of SARS and directing initial management...
  4. ncbi Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome
    Matthew P Muller
    Department of Microbiology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
    Pharmacotherapy 27:494-503. 2007
    ..To distinguish adverse events related to ribavirin therapy from those attributable to severe acute respiratory syndrome (SARS), and to determine the rate of potential ribavirin-related adverse events...
  5. ncbi Severe acute respiratory syndrome
    Michael D Christian
    Toronto General Hospital, University Health Network, Toronto, Ontario, Canada
    Clin Infect Dis 38:1420-7. 2004
    ..We present an overview of the epidemiology, clinical presentation, diagnosis, and treatment of SARS based on the current state of knowledge derived from published studies and our own personal experience...
  6. ncbi Rapid control of a methicillin resistant Staphylococcus aureus (MRSA) outbreak in a medical surgical intensive care unit (ICU)
    Anjum Khan
    St Michael s Hospital, Toronto, Ontario, Canada
    Can J Infect Control 24:12-6. 2009
    ..Complete cessation of transmission occurred after the initiation of decolonization for all positive patients...
  7. ncbi Clinical trials and novel pathogens: lessons learned from SARS
    Matthew P Muller
    Mount Sinai Hospital, Toronto, Ontario, Canada
    Emerg Infect Dis 10:389-94. 2004
    ..Strategies to facilitate future clinical trials during outbreaks of unknown or novel pathogens are also presented...
  8. ncbi Severe acute respiratory syndrome (SARS) coronavirus
    Matthew P Muller
    Department of Microbiology, Mount Sinai Hospital, Toronto, Ontario, Canada
    Semin Respir Crit Care Med 28:201-12. 2007
    ..This review discusses the likelihood of another SARS pandemic and reviews the epidemiological and clinical features of the disease with an emphasis on the clinical presentation, diagnosis, and management of SARS...
  9. ncbi Impact of a mandatory infection control education program on nosocomial acquisition of methicillin-resistant Staphylococcus aureus
    Todd C Lee
    University of Toronto, Canada
    Infect Control Hosp Epidemiol 30:249-56. 2009
    ..To assess the impact of an institution-wide infection control education program on the rate of transmission of methicillin-resistant Staphylococcus aureus (MRSA)...
  10. ncbi One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome
    Catherine M Tansey
    Department of Medicine, University Health Network, and Mount Sinai Hospital, Toronto, Ontario, Canada
    Arch Intern Med 167:1312-20. 2007
    ..Research conducted during the SARS outbreak may help inform research planning for future public health emergencies. The objective of this study was to evaluate the 1-year outcomes in survivors of SARS and their family caregivers...
  11. ncbi Human immunopathogenesis of severe acute respiratory syndrome (SARS)
    Mark J Cameron
    University Health Network, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada
    Virus Res 133:13-9. 2008
    ..We contend that dysregulated type I and II interferon (IFN) responses during SARS may culminate in a failure of the switch from hyper-innate immunity to protective adaptive immune responses in the human host...
  12. ncbi Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome
    Mark J Cameron
    Division of Experimental Therapeutics, University Health Network, MaRS Centre, 3 916 TMDT, 101 College Street, Toronto, Ontario, Canada
    J Virol 81:8692-706. 2007
    ....
  13. ncbi Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia?
    Matthew P Muller
    Department of Medicine, University of Toronto, Toronto, Ontario, Canada
    Clin Infect Dis 40:1079-86. 2005
    ..Hematological and biochemical abnormalities, particularly lymphopenia, are common in patients with SARS...
  14. ncbi Alternative methods of estimating an incubation distribution: examples from severe acute respiratory syndrome
    Benjamin J Cowling
    Department of Community Medicine, School of Public Health, University of Hong Kong, Pokfulam, Hong Kong
    Epidemiology 18:253-9. 2007
    ..Accurate and precise estimates of the incubation distribution of novel, emerging infectious diseases are vital to inform public health policy and to parameterize mathematical models...
  15. ncbi Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada
    David A Boyd
    Nosocomial Infections, National Microbiology Laboratory, 1015 Arlington St, Winnipeg, Manitoba, Canada
    Antimicrob Agents Chemother 48:3758-64. 2004
    ..coli strain isolated in India in 1999, revealed that the plasmids had several features in common, including an R100 backbone and several of the resistance genes, including bla(CTX-M-15), bla(TEM-1), bla(OXA-1), tetA, and aac(6')-Ib...
  16. ncbi Clinical prognostic rules for severe acute respiratory syndrome in low- and high-resource settings
    Benjamin J Cowling
    Department of Community Medicine and School of Public Health, The University of Hong Kong, Pokfulam, Hong Kong
    Arch Intern Med 166:1505-11. 2006
    ..877 and 0.892 in the derivation and validation cohorts, respectively. CONCLUSION: The model performs well and could be useful in assessing prognosis for patients who are infected with re-emergent SARS...
  17. ncbi Development of a triage protocol for critical care during an influenza pandemic
    Michael D Christian
    Division of Infectious Diseases and Critical Care, Department of Postgraduate Medicine, McMaster University, Hamilton, Ont
    CMAJ 175:1377-81. 2006
    ..Of particular concern in this planning is the allocation of resources, such as ventilators and antiviral medications, which will likely become scarce during a pandemic...